Detalhe da pesquisa
1.
What is the best first choice oral drug therapy for OAB?
Neurourol Urodyn
; 2024 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38270332
2.
Does COVID-19 cause or worsen LUT dysfunction, what are the mechanisms and possible treatments? ICI-RS 2023.
Neurourol Urodyn
; 2024 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38506116
3.
Should hormone replacement therapy (any route of administration) be considered in all postmenopausal women with lower urinary tract symptoms? Report from the ICI-RS 2023.
Neurourol Urodyn
; 2024 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38289324
4.
A consensus statement on when to start clean intermittent self-catheterization: An untapped resource?
Neurourol Urodyn
; 43(2): 459-463, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38078751
5.
Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI-RS 2023.
Neurourol Urodyn
; 2024 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38477358
6.
Can we predict whether a man with acute or chronic urinary retention will void after bladder outflow resistance reduction surgery? ICI-RS 2023.
Neurourol Urodyn
; 2024 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38291822
7.
Exploring lifelong overactive bladder: Transitions, evidence, and clinical implications; A modified Delphi process.
Neurourol Urodyn
; 43(5): 1040-1057, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38289322
8.
How do we make progress in phenotyping patients with lower urinary tract such as overactive bladder and underactive detrusor, including using urine markers and microbiome data, to personalize therapy? ICI-RS 2023-Part 2.
Neurourol Urodyn
; 2024 Jan 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38178629
9.
How do we make progress in phenotyping patients with LUT such as OAB and underactive detrusor, including using urine markers and microbiome data, in order to personalize therapy? ICI-RS 2023: Part 1.
Neurourol Urodyn
; 2024 Jan 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38178627
10.
Nocturia in Menopausal Women: The Link Between Two Common Problems of the Middle Age.
Int Urogynecol J
; 35(5): 935-946, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38436669
11.
Evaluation of new treatments for benign prostatic obstruction: ICI-RS 2023.
Neurourol Urodyn
; 2023 Dec 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38078704
12.
Nitric oxide signaling pathways in the normal and pathological bladder: Do they provide new pharmacological pathways?-ICI-RS 2023.
Neurourol Urodyn
; 2023 Oct 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37902298
13.
How should we assess the cardiovascular system in patients presenting with bothersome nocturia? ICI-RS 2023.
Neurourol Urodyn
; 2023 Nov 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37942826
14.
New therapeutic targets to prevent benign prostatic enlargement and symptomatic progression to benign prostatic obstruction-ICI-RS 2023.
Neurourol Urodyn
; 2023 Nov 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37916442
15.
Can we improve techniques and patients' selection for nerve stimulation suitable for lower urinary tract dysfunctions? ICI-RS 2023.
Neurourol Urodyn
; 2023 Dec 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38048061
16.
Beyond the urothelium: Interplay between autonomic nervous system and bladder inflammation in urinary tract infection, bladder pain syndrome with interstitial cystitis and neurogenic lower urinary tract dysfunction in spinal cord injury-ICI-RS 2023.
Neurourol Urodyn
; 2023 Oct 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37876314
17.
How does the lower urinary tract contribute to bladder sensation? ICI-RS 2023.
Neurourol Urodyn
; 2023 Oct 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37902296
18.
Which parameters, related to the female urethra and pelvic floor, determine therapy selection for recurrent female stress urinary incontinence: ICI-RS 2023?
Neurourol Urodyn
; 2023 Nov 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37937374
19.
Can we define the optimal postvoid residual volume at which intermittent catheterization should be recommended, and are there other measures that could guide an intermittent catheterization protocol: ICI-RS 2023.
Neurourol Urodyn
; 2023 Oct 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37905437
20.
Could a better understanding of the underlying pathophysiologies lead to more informed treatment choices in patients with lower urinary tract dysfunction due to an acontractile or underactive detrusor? ICI-RS 2023.
Neurourol Urodyn
; 2023 Nov 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37960931